Citadel Advisors
WINT

Citadel Advisors’s Windtree Therapeutics WINT Stock Holding History

Citadel Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12
Closed -$3.77K – 15633
2024
Q1 		$3.77K Sell
12
-30
-71% -$11.5K ﹤0.01% 13870
2023
Q4 		$27.4K Buy
+42
New +$37K ﹤0.01% 12338
2023
Q3 		– Sell
-24
Closed -$27.3K – 15307
2023
Q2 		$27.3K Buy
+24
New +$48.7K ﹤0.01% 12452
2022
Q1 		– Sell
-1
Closed -$66K – 14884
2021
Q4 		$66K Buy
+1
New +$80K ﹤0.01% 13084
2021
Q3 		– Hold
0
– -$30K – 14935
2021
Q2 		– Sell
-1
Closed -$97.3K – 13481
2021
Q1 		$162K Buy
+1
New +$216K ﹤0.01% 11956

Other funds holding WINT

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $569M AUM 21.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return